Anti-CXCL2/ CINC-2a/ GRO2 functional antibody

Anti-CXCL2/ CINC-2a/ GRO2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CXCL2/CXCL2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T96627-Ab-1/ GM-Tg-hg-T96627-Ab-2Anti-Human CXCL2 monoclonal antibodyHuman
GM-Tg-rg-T96627-Ab-1/ GM-Tg-rg-T96627-Ab-2Anti-Rat CXCL2 monoclonal antibodyRat
GM-Tg-mg-T96627-Ab-1/ GM-Tg-mg-T96627-Ab-2Anti-Mouse CXCL2 monoclonal antibodyMouse
GM-Tg-cynog-T96627-Ab-1/ GM-Tg-cynog-T96627-Ab-2Anti-Cynomolgus/ Rhesus macaque CXCL2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T96627-Ab-1/ GM-Tg-felg-T96627-Ab-2Anti-Feline CXCL2 monoclonal antibodyFeline
GM-Tg-cang-T96627-Ab-1/ GM-Tg-cang-T96627-Ab-2Anti-Canine CXCL2 monoclonal antibodyCanine
GM-Tg-bovg-T96627-Ab-1/ GM-Tg-bovg-T96627-Ab-2Anti-Bovine CXCL2 monoclonal antibodyBovine
GM-Tg-equg-T96627-Ab-1/ GM-Tg-equg-T96627-Ab-2Anti-Equine CXCL2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T96627-Ab-1/ GM-Tg-hg-T96627-Ab-2; GM-Tg-rg-T96627-Ab-1/ GM-Tg-rg-T96627-Ab-2;
GM-Tg-mg-T96627-Ab-1/ GM-Tg-mg-T96627-Ab-2; GM-Tg-cynog-T96627-Ab-1/ GM-Tg-cynog-T96627-Ab-2;
GM-Tg-felg-T96627-Ab-1/ GM-Tg-felg-T96627-Ab-2; GM-Tg-cang-T96627-Ab-1/ GM-Tg-cang-T96627-Ab-2;
GM-Tg-bovg-T96627-Ab-1/ GM-Tg-bovg-T96627-Ab-2; GM-Tg-equg-T96627-Ab-1/ GM-Tg-equg-T96627-Ab-2
Products NameAnti-CXCL2 monoclonal antibody
Formatmab
Target NameCXCL2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CXCL2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T96627-Ag-1Recombinant multi-species CXCL2/ CINC-2a/ GRO2 protein
    CytokineGM-Tg-g-T96627-Ag-1chemokine (C-X-C motif) ligand 2 (CXCL2) protein
    ORF Viral VectorpGMLP000632human CXCL2 Lentivirus plasmid
    ORF Viral VectorvGMLP000632human CXCL2 Lentivirus particle
    ORF Viral VectorpGMLPm000070mouse Cxcl2 Lentivirus plasmid
    ORF Viral VectorvGMLPm000070mouse Cxcl2 Lentivirus particle


    Target information

    Target IDGM-T96627
    Target NameCXCL2
    Gene ID2920
    Gene Symbol and SynonymsCINC-2a,CXCL2,GRO2,GROb,MGSA-b,MIP-2a,MIP2,MIP2A,SCYB2
    Uniprot AccessionP19875
    Uniprot Entry NameCXCL2_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, Cytokine Target
    DiseaseProstate Cancer
    Gene EnsemblENSG00000081041
    Target ClassificationN/A

    The target: CXCL2, gene name: CXCL2, also named as CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, MIP2, MIP2A, SCYB2. This antimicrobial gene is part of a chemokine superfamily that encodes secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of the N-terminal cysteine residues of the mature peptide. This chemokine, a member of the CXC subfamily, is expressed at sites of inflammation and may suppress hematopoietic progenitor cell proliferation. [provided by RefSeq, Sep 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.